Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation 

Slides:



Advertisements
Similar presentations
Assessment of mouse hind limb endothelial function by measuring femoral artery blood flow responses  Chao-Hung Wang, MD, Kuo-Ti Chen, MS, Hsiu-Fu Mei,
Advertisements

Volume 144, Issue 1, Pages 7-14 (May 1999)
Expression of molecular mediators of apoptosis and their role in the pathogenesis of lower-extremity varicose veins  Enrico Ascher, MD, Theresa Jacob,
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury 
Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice  Ryotaro Hashizume, MD, Aika Yamawaki-Ogata,
Accelerated aneurysmal dilation associated with apoptosis and inflammation in a newly developed calcium phosphate rodent abdominal aortic aneurysm model 
Robert J. Pitsch, MD, David J. Minion, MD, Margaret L
Elevation of hemopexin-like fragment of matrix metalloproteinase-2 tissue levels inhibits ischemic wound healing and angiogenesis  April E. Nedeau, MD,
Increased endogenous angiogenic response and hypoxia-inducible factor-1α in human critical limb ischemia  Teik K. Ho, MRCS, Vineeth Rajkumar, MSc, Markella.
Folic acid inhibits homocysteine-induced proliferation of human arterial smooth muscle cells  Brennan J. Carmody, MD, Subodh Arora, MD, Ricardo Avena,
A patient with multiple paradoxical emboli
Comparative proteomics reveals a systemic vulnerability in the vasculature of patients with abdominal aortic aneurysms  Ian M. Nordon, MD, FRCS, Robert.
Bertrand Poussier, MD, Alfredo C
Potential role of erythropoietin receptors and ligands in attenuating apoptosis and inflammation in critical limb ischemia  Dhiraj Joshi, MD, MRCS, David.
Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix  Sung Shin, MD, Yong-Pil.
Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature  Nick D. Tsihlis, PhD, Muneera R.
Intermittent cyclic mechanical tension promotes endplate cartilage degeneration via canonical Wnt signaling pathway and E-cadherin/β-catenin complex cross-talk 
Volume 9, Issue 5, Pages (May 2004)
The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling 
Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis 
High-mobility-group box protein 1 A box reduces development of sodium laurate- induced thromboangiitis obliterans in rats  Xiangqian Kong, MD, Hai Yuan,
Association of smooth muscle cell phenotypes with extracellular matrix disorders in thoracic aortic dissection  Lixin Wang, MD, PhD, Jing Zhang, MD, PhD,
Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated.
Expression of heat shock protein–70 by dendritic cells in the arterial intima and its potential significance in atherogenesis  Yuri V. Bobryshev, PhD,
Ryan M. McEnaney, MD, Ankur Shukla, MD, Michael C
Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft  Mitsuteru Handa, MD, Wei Li,
The role of progenitor cells in the development of intimal hyperplasia
Adenovirus-mediated intra-arterial delivery of cellular repressor of E1A-stimulated genes inhibits neointima formation in rabbits after balloon injury 
Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques  Alessandra Bitto, MD, Giovanni De Caridi, MD, Francesca.
Potential role of erythropoietin receptors and ligands in attenuating apoptosis and inflammation in critical limb ischemia  Dhiraj Joshi, MD, MRCS, David.
In situ localization and quantification of seventy-two – kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta  William D. McMillan,
Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening  David A. Vorp, PhDa,b,c, Paul C. Lee, MDa, David.
Pingping Ren, MD, Lin Zhang, MS, Gaiping Xu, MD, Laura C
Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival  Johan.
Mechanosensitive transient receptor potential vanilloid type 1 channels contribute to vascular remodeling of rat fistula veins  Yih-Sharng Chen, MD, PhD,
The first operation on the profunda femoris artery
Leptin receptor is elevated in carotid plaques from neurologically symptomatic patients and positively correlated with augmented macrophage density  Jacob.
Jing Wen, MD, Peiyi Wang, MS, Sumona V. Smith, MD, Carolyn A
Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model  David G. Neschis,
Autophagy-mediated stress response in motor neurons after hypothermic spinal cord ischemia in rabbits  Satoshi Fujita, MD, Masahiro Sakurai, MD, PhD,
Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype  Hector F. Simosa, MD, Grace Wang, MD, XinXin Sui,
Assessment of mouse hind limb endothelial function by measuring femoral artery blood flow responses  Chao-Hung Wang, MD, Kuo-Ti Chen, MS, Hsiu-Fu Mei,
Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft  Mitsuteru Handa, MD, Wei Li,
Comparison of cell-type-specific vs transmural aortic gene expression in experimental aneurysms  Eiketsu Sho, MD, PhD, Mien Sho, MD, Hiroshi Nanjo, MD,
Delayed inhaled carbon monoxide mediates the regression of established neointimal lesions  Michael Madigan, MD, Fateh Entabi, MD, Brian Zuckerbraun, MD,
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis  Masayuki Kubo, PhD, Tao-Sheng Li, MD, PhD, Takahiro.
Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD 
Stem Cells in Thoracic Aortic Aneurysms and Dissections: Potential Contributors to Aortic Repair  Ying H. Shen, MD, PhD, Xiaoqing Hu, MD, Sili Zou, MD,
Protein kinase C-δ regulates migration and proliferation of vascular smooth muscle cells through the extracellular signal-regulated kinase 1/2  Bo Liu,
Aortic wall cell proliferation via basic fibroblast growth factor gene transfer limits progression of experimental abdominal aortic aneurysm  Katsuyuki.
Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques  Benjamin J. Dunmore, PhD, Mark J. McCarthy,
In vitro differences between smooth muscle cells derived from varicose veins and normal veins  Ying Xiao, PhD, Zhibin Huang, MD, Henghui Yin, PhD, Ying.
Ischemic preconditioning ameliorates spinal cord ischemia-reperfusion injury by triggering autoregulation  Cheng-Loong Liang, MD, Kang Lu, MD, PhD, Po-Chou.
Cathepsin G deficiency reduces periaortic calcium chloride injury-induced abdominal aortic aneurysms in mice  Jing Wang, MD, PhD, Galina K. Sukhova, PhD,
Biologic degeneration of vein grafts after thrombotic occlusion: thrombectomy within 3 days results in better indices of viability  Shigehisa Kawai, MD,
Autophagy-mediated stress response in motor neuron after transient ischemia in rabbits  Hironori Baba, MD, Masahiro Sakurai, MD, PhD, Koji Abe, MD, PhD,
Volume 26, Issue 8, Pages (August 2018)
Development of a spontaneously beating vein by cardiomyocyte transplantation in the wall of the inferior vena cava in a rat: A pilot study  Wangde Dai,
Differential proteolytic activity and induction of apoptosis in fibrous versus atheromatous plaques in carotid atherosclerotic disease  Theresa Jacob,
Boulos Toursarkissian, MD, David Schwartz, MD, PhD, Paul R
Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery  Russell C. Lam,
Tuberculous pseudoaneurysm of the femoral artery complicated by cutaneous tuberculosis of the foot: A case report  Kathryn Leccese, BSc, José Ferreira,
Michael L. Marin, MD, Ronald E. Gordon, PhD, Frank J
Activation of integrin receptors is required for growth factor–induced smooth muscle cell dysfunction  Kyotaro Mawatari, MD, Bo Liu, PhD, K.Craig Kent,
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts  Hiroshi Banno, MD, Yoshifumi Takei, PhD,
Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation  Takashi Munezane, MD, Tomomi Hasegawa,
A giant common carotid artery pseudoaneurysm after penetrating injury
Presentation transcript:

Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation  Rachel S. Edlin, BS, Shirling Tsai, MD, Dai Yamanouchi, MD, PhD, Chunjie Wang, MD, Bo Liu, PhD, K. Craig Kent, MD  Journal of Vascular Surgery  Volume 49, Issue 5, Pages 1289-1295 (May 2009) DOI: 10.1016/j.jvs.2008.11.096 Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Fig 1 Immunohistochemical analysis of human atherosclerotic and restenotic lesions. Immunohistochemistry of primary atherosclerotic (n = 5) and restenotic lesions (n = 3). Representative sections are shown. Staining for (A) α-actin, (B) PCNA, (C) CD68, and (D) CD45. Magnification ×400. E, Quantification of positive immunostaining in restenotic or primary atherosclerotic lesions expressed as a ratio of positive/total cells ± standard error (*P < .001 restenotic compared with primary lesions). Journal of Vascular Surgery 2009 49, 1289-1295DOI: (10.1016/j.jvs.2008.11.096) Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Fig 2 Smad3 staining of human atherosclerotic and restenotic lesions. Smad3 staining of primary atherosclerotic lesions (n = 5) and restenotic lesions (n = 3). Representative sections are shown. Magnification ×400. Journal of Vascular Surgery 2009 49, 1289-1295DOI: (10.1016/j.jvs.2008.11.096) Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Fig 3 Colocalization of Smad3 with α-actin and PCNA. Double immunofluorescent staining of restenotic plaque. A, Staining reveals (a) nuclei (blue), (b) nuclear Smad3 (green), (c) α -actin (red), and (d) colocalization (nuclear green surrounded by cytoplasmic red) (white arrows). B, Staining reveals (a) nuclei (blue), (b) nuclear Smad3 (green), (c) nuclear PCNA (red), and (d) colocalization (yellow) (white arrows). Journal of Vascular Surgery 2009 49, 1289-1295DOI: (10.1016/j.jvs.2008.11.096) Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Fig 4 The effect of Smad3 on human SMC proliferation. A, Western blotting of human aortic SMCs demonstrating the effects of Smad3 overexpression via AdSmad3 infection and Smad3 downregulation via transient transfection with Smad3 siRNA. B, 3H-thymidine incorporation in human aortic SMCs following overexpression or inhibition of Smad3 (n = 3, *P < .001 compared with AdLacZ or scrambled control). Journal of Vascular Surgery 2009 49, 1289-1295DOI: (10.1016/j.jvs.2008.11.096) Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Fig 5 The effect of Smad3 on SMC apoptosis. Vascular SMCs were infected with AdLacZ or AdSmad3, then lysed and analyses for apoptosis using ELISA. *P < .05 compared with negative control. Journal of Vascular Surgery 2009 49, 1289-1295DOI: (10.1016/j.jvs.2008.11.096) Copyright © 2009 Society for Vascular Surgery Terms and Conditions